Mass Spectrometry Imaging-Based Single-Cell Lipidomics Profiles Metabolic Signatures of Heart Failure

• Published in: Research (Washington) 2023, Vol.6, p.0019-0019
• Main Authors: Ren, Jie, Li, Hao-Wen, Chen, Liang, Zhang, Min, Liu, Yan-Xiang, Zhang, Bo-Wen, Xu, Rui, Miao, Yan-Yan, Xu, Xue-Mei, Hua, Xin, Sun, Xiao-Gang, Yu, Ru-Jia, Long, Yi-Tao, Hu, Sheng-Shou
• Format: Article
• Language: English
• ISSN: 2639-5274; 2639-5274
• DOI: 10.34133/research.0019

Heart failure (HF), leading as one of the main causes of mortality, has become a serious public health issue with high prevalence around the world. Single cardiomyocyte (CM) metabolomics promises to revolutionize the understanding of HF pathogenesis since the metabolic remodeling in the human hearts plays a vital role in the disease progression. Unfortunately, current metabolic analysis is often limited by the dynamic features of metabolites and the critical needs for high-quality isolated CMs. Here, high-quality CMs were directly isolated from transgenic HF mice biopsies and further employed in the cellular metabolic analysis. The lipids landscape in individual CMs was profiled with a delayed extraction mode in time-of-flight secondary ion mass spectrometry. Specific metabolic signatures were identified to distinguish HF CMs from the control subjects, presenting as possible single-cell biomarkers. The spatial distributions of these signatures were imaged in single cells, and those were further found to be strongly associated with lipoprotein metabolism, transmembrane transport, and signal transduction. Taken together, we systematically studied the lipid metabolism of single CMs with a mass spectrometry imaging method, which directly benefited the identification of HF-associated signatures and a deeper understanding of HF-related metabolic pathways.